“It’s extremely rare to see this type of tumor invading into the major blood vessels of the heart,” said Chris Mehta, M.D. — ...
An Illinois mom is thankful as she looks forward to celebrating her first Christmas with her son — months after doctors ...
A new study has identified one of the reasons why cancer frequently spreads from elsewhere in the body to the lungs: an amino ...
Researchers at Tel Aviv University have developed a new platform using polymeric nanoparticles to deliver drug pairs to ...
As tumor blood vessels are characterized by multiple angiogenic markers, further investigation is required to enhance the targeting specificity achieved by combining several ligands on one ...
FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...
WLKY Louisville on MSN2d
Hyperbaric oxygen therapy at UofL Health paving new way for patient with rare blood diseaseNoah Barone is the first patient in the world with Erdheim-Chester Disease to undergo Hyperbaric Oxygen Therapy to treat the ...
Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and ...
The researchers developed nanoparticles, which dissolve into water and carbon dioxide within a month, to encapsulate two ...
Fred Hutch graduate student Adam Nguyen has won a F31 training award from the NIH to study a complex molecule called Tie2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback